IP Library Granted Patent US 11,065,262
Granted Patent B2
US 11,065,262 · App. 16/047,464 · Granted Jul 20, 2021

Topical treatment of wounds with statins and cholesterol for scar reduction

Inventors: Thomas A. Mustoe (Evanston, IL); Robert D. Galiano (Chicago, IL); Seok Jong Hong (Northbrook, IL); Ping Xie (Chicago, IL); Shengxian Jia (Wilmette, IL)
Assignee: Northwestern University
A61K31/575A61K9/0014A61K9/06A61K9/107A61K9/1075A61K9/14A61K31/22A61K31/225A61K31/366A61K45/06A61K47/10A61K47/12A61K47/14A61K47/44A61P17/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,065,262
App. No.
16/047,464
Granted
Jul 20, 2021
Kind
B2
Abstract

Provided herein are compositions, systems, and methods for treating wounds with the combination of statins and cholesterol to help prevent and reduce scar formation.

Claims (20)

1. A method of preventing or reducing scar formation in the skin of a subject during wound healing comprising:

administering a composition topically to a wound site of a subject such that scar tissue formation in said skin is reduced or prevented during wound healing,

wherein said administering occurs at least two weeks after said wound site is generated and is repeated daily for at least one week,

wherein said composition comprises:

i) a pharmaceutically acceptable carrier,

ii) a statin at a concentration of 6-10% of said pharmaceutically acceptable carrier, and

iii) cholesterol, cholesterol derivative, or cholesterol analog at 1-15% of said pharmaceutically acceptable carrier.

2. The method of claim 1 , said cholesterol derivative is a cholesterol ester selected from the group consisting of: cholesteryl capronate, cholesteryl pelargonate, cholesteryl caprinate, cholesteryl undecilate, cholesteryl laurate, cholesteryl tridecilate, cholesteryl miristinate, cholesteryl palmitate, and cholesteryl stearate.

3. The method of claim 1 , wherein said cholesterol analog is selected from the group consisting of: sitosterol, stigmasterol, fucosterol, spinasterol, campesterol, brassicasterol and ergosterol.

4. The method of claim 1 , wherein said statin is selected from the group consisting of: simvastatin, rosuvastatin, lovastatin, cerivastatin, fluvastatin, mevastatin, pitavastatin, and pravastatin.

5. The method of claim 1 , wherein said statin has molecular weight less than 500 daltons.

6. The method of claim 1 , wherein said wound site comprises at least some scar tissue.

7. The method of claim 1 , wherein said composition comprises an emulsion.

8. The method of claim 7 , wherein said emulsion comprises an oil-in-water emulsion.

9. The method of claim 7 , wherein said emulsion comprises a water-in-oil emulsion.

10. The method of claim 7 , wherein said emulsion comprises a surfactant and a solvent.

11. The method of claim 10 , wherein said surfactant comprises monoacylglycerols.

12. The method of claim 10 , where solvent is selected from the group consisting of: water, polyethylene glycol, oleic acid, and 2-(2-ethoxyethoxy) ethanol.

13. The method of claim 1 , wherein said composition comprises a form selected from the group consisting of: a powder, a spray, an ointment, a paste, a cream, a lotion, and a gel.

14. The method of claim 1 , wherein said composition comprises vegetable oil.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE TYPO IN INVENTOR ROBERT D. GALIANO'S NAME PREVIOUSLY RECORDED ON REEL 048959 FRAME 0104. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNORS INTEREST. Recorded Apr 24, 2019
From: MUSTOE, THOMAS A.; GALIANO, ROBERT D.; HONG, SEOK JONG; XIE, PING; JIA, SHENGXIAN
To: NORTHWESTERN UNIVERSITY
Reel/Frame 051073/0775 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2019
From: MUSTOE, THOMAS A.; GALLIANO, ROBERT D.; HONG, SEOK JONG; XIE, PING; JIA, SHENGXIAN
To: NORTHWESTERN UNIVERSITY
Reel/Frame 048959/0104 →
Continuity (2)
Provisional Application 62537534 · Jul 27, 2017
Related Publication 20190030045A1 · Jan 31, 2019